ERO1A and neoplasm: We found that the regulation of ERO1α was sensitive to KYNU-induced changes in the redox environment, which stimulate the PERK-eIF2α-ATF4 pathway, promote oxidative folding, reduce the number of MFPs, and thereby maintain tumor survival and progression.